Effects of MDMA on sociability and neural response to social threat and social reward
- 1.3k Downloads
±3,4-Methylenedioxymethamphetamine (MDMA, “ecstasy”) reportedly produces unique subjective effects, including increased sociability, feelings of closeness with others, and reduced interpersonal defensiveness. Despite their apparent importance in recreational and potential psychotherapeutic use of MDMA, the defining characteristics and neurobiological mechanisms of these interpersonal effects are poorly understood.
Materials and methods
We investigated acute effects of MDMA on self-reported sociability and neuronal activation in response to socially threatening (angry and fearful faces) and socially rewarding (happy faces) stimuli. Assessment of social threat response focused on amygdala activation, whereas assessment of social reward focused on ventral striatum activation. Healthy volunteers (N = 9) reporting past ecstasy use completed three experimental sessions, receiving MDMA (0.75 and 1.5 mg/kg) and placebo (PBO) under double-blind conditions. During peak drug effects, participants underwent functional magnetic resonance imaging while viewing standardized images depicting emotional facial expressions including angry, fearful, happy, and neutral expressions. They also completed standardized self-report measures of sociability.
MDMA (1.5 mg/kg) increased self-reported sociability compared to MDMA (0.75 mg/kg) and PBO. MDMA (1.5 mg/kg) attenuated left amygdala response to angry facial expressions compared to PBO, but MDMA did not affect amygdala reactivity to fearful expressions. MDMA (0.75 mg/kg) enhanced ventral striatum response to happy expressions relative to PBO.
These data present the first evidence that MDMA may increase sociability in humans both by diminishing responses to threatening stimuli and enhancing responses to rewarding social signals.
KeywordsMDMA Ecstasy Social reward Social threat Sociability
Thanks to Gina Beguhn, David Hyman, Patricia Kriegal, Robert Lyons, and Rosemary McCarron for technical assistance; to Royce Lee for medical support; and Emmanuel Semmes for pharmaceutical support. Thanks also to participants. This research was supported by National Institute of Drug Abuse (DA02812).
Disclosures/conflict of interest
- Anderson IM, Del-Ben CM, Mckie S, Richardson P, Williams SR, Elliott R et al (2007) Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study. Neuro Report 18:1351–1355Google Scholar
- APA (1994) DSM-IV: diagnostic and statistical manual of mental disorders. American Psychiatric Association, MDGoogle Scholar
- Ekman P, Friesen WV (1976) Pictures of facial affect. Consulting Psychologists, Palo AltoGoogle Scholar
- Holmes AP, Friston KJ (1998) Generalisability, random effects and population inference. NeuroImage 7:S754Google Scholar
- McNair DLM, Droppleman L (1971). Profile of mood states. Educational and Industrial Testing Service: San DiegoGoogle Scholar
- Walter B, Blecker C, Kirsch P, Sammer G, Schlienle A, Stark R, et al (2003). MARINA: An easy to use tool for the creation of MAsks for Region of INterest Analyses. Paper presented at Ninth International Conference on Functional Mapping of the Human Brain New York, NY, JuneGoogle Scholar